{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T04:29:22Z","timestamp":1726892962306},"reference-count":58,"publisher":"Impact Journals, LLC","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2024,9,15]]},"DOI":"10.18632\/aging.206088","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T15:46:58Z","timestamp":1725032818000},"page":"12312-12334","source":"Crossref","is-referenced-by-count":0,"title":["Identification of a circadian-based prognostic signature predicting cancer-associated fibroblasts infiltration and immunotherapy response in bladder cancer"],"prefix":"10.18632","volume":"16","author":[{"given":"Li","family":"Zhou","sequence":"first","affiliation":[{"name":"Institute of Interdisciplinary Research, Guangdong Polytechnic Normal University, Guangzhou, Guangdong, China"},{"name":"Research Institute of Guangdong Polytechnic Normal University in Heyuan City, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaming","family":"He","sequence":"additional","affiliation":[{"name":"Institute of Biotherapy, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiming","family":"Hu","sequence":"additional","affiliation":[{"name":"Institute of Biotherapy, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongwei","family":"Li","sequence":"additional","affiliation":[{"name":"Institute of Biotherapy, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinlong","family":"Li","sequence":"additional","affiliation":[{"name":"Institute of Biotherapy, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2024,8,30]]},"reference":[{"key":"1","unstructured":"Cancer Stat Facts: Bladder Cancer. https:\/\/seer.cancer.gov\/statfacts\/html\/urinb.html."},{"key":"2","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3390\/cancers16020335","article-title":"A Comprehensive Review of Immunotherapy Clinical Trials for Metastatic Urothelial Carcinoma: Immune Checkpoint Inhibitors Alone or in Combination, Novel Antibodies, Cellular Therapies, and Vaccines.","volume":"1","author":"Collier","year":"2024","journal-title":"Cancers (Basel)"},{"key":"3","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3390\/cancers16010131","article-title":"Current Landscape of Immune Checkpoint Inhibitors for Metastatic Urothelial Carcinoma: Is There a Role for Additional T-Cell Blockade?","volume":"1","author":"Chipollini","year":"2023","journal-title":"Cancers (Basel)"},{"key":"4","doi-asserted-by":"publisher","first-page":"2255459","DOI":"10.1080\/2162402X.2023.2255459","article-title":"Non-pharmaceutical interventions to optimize cancer immunotherapy.","volume":"1","author":"Brutsche","year":"2023","journal-title":"Oncoimmunology"},{"key":"5","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.trecan.2019.07.002","article-title":"Interplay between Circadian Clock and Cancer: New Frontiers for Cancer Treatment.","volume":"5","author":"Panda","year":"2019","journal-title":"Trends Cancer"},{"key":"6","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.immuni.2016.12.011","article-title":"Lymphocyte Circadian Clocks Control Lymph Node Trafficking and Adaptive Immune Responses.","volume":"4","author":"Sander","year":"2017","journal-title":"Immunity"},{"key":"7","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1016\/S1470-2045(21)00546-5","article-title":"Effect of immunotherapy time-of-day infusion on overall survival among patients with advanced melanoma in the USA (MEMOIR): a propensity score-matched analysis of a single-centre, longitudinal study.","volume":"2","author":"Buchwald","year":"2021","journal-title":"Lancet Oncol"},{"key":"8","doi-asserted-by":"publisher","first-page":"896","DOI":"10.3390\/cancers14040896","article-title":"Time-Dependent Efficacy of Checkpoint Inhibitor Nivolumab: Results from a Pilot Study in Patients with Metastatic Non-Small-Cell Lung Cancer.","volume":"1","author":"L\u00e9vi","year":"2022","journal-title":"Cancers (Basel)"},{"key":"9","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.3390\/cancers15061899","article-title":"Cancer-Associated Fibroblasts: Master Tumor Microenvironment Modifiers.","volume":"1","author":"Thomas","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","article-title":"A framework for advancing our understanding of cancer-associated fibroblasts.","volume":"2","author":"Janowitz","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"11","doi-asserted-by":"publisher","first-page":"12954","DOI":"10.3390\/ijms232112954","article-title":"Role of Circadian Transcription Factor Rev-Erb in Metabolism and Tissue Fibrosis.","volume":"2","author":"Herzig","year":"2022","journal-title":"Int J Mol Sci"},{"key":"12","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/s41581-018-0048-9","article-title":"Circadian rhythms and the kidney.","volume":"1","author":"Bonny","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"13","doi-asserted-by":"publisher","first-page":"e2301505","DOI":"10.1002\/advs.202301505","article-title":"Disruption of the Clock Component Bmal1 in Mice Promotes Cancer Metastasis through the PAI-1-TGF-\u03b2-myoCAF-Dependent Mechanism.","volume":"1","author":"Cao","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"14","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41419-020-2468-2","article-title":"Effect of naive and cancer-educated fibroblasts on colon cancer cell circadian growth rhythm.","volume":"1","author":"Laukkanen","year":"2020","journal-title":"Cell Death Dis"},{"key":"15","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12935-023-02926-6","article-title":"Construction of a CCL20-centered circadian-signature based prognostic model in cervical cancer.","volume":"2","author":"Fan","year":"2023","journal-title":"Cancer Cell Int"},{"key":"16","doi-asserted-by":"publisher","first-page":"10140","DOI":"10.3390\/ijms241210140","article-title":"Disruptions of Circadian Genes in Cutaneous Melanoma-AnAnalysis of Transcriptome Databases.","volume":"2","author":"Reszka","year":"2023","journal-title":"Int J Mol Sci"},{"key":"17","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/s41586-023-06130-4","article-title":"Hallmarks of transcriptional intratumour heterogeneity across a thousand tumours.","volume":"61","author":"Gonzalez Castro","year":"2023","journal-title":"Nature"},{"key":"18","doi-asserted-by":"publisher","first-page":"D104","DOI":"10.1093\/nar\/gkaa1057","article-title":"GTRD: an integrated view of transcription regulation.","volume":"4","author":"Kolpakov","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"19","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nature03441","article-title":"Systematic discovery of regulatory motifs in human promoters and 3' UTRs by comparison of several mammals.","volume":"43","author":"Kellis","year":"2005","journal-title":"Nature"},{"key":"20","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data.","volume":"4","author":"Stemke-Hale","year":"2013","journal-title":"Nat Commun"},{"key":"21","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles.","volume":"1","author":"Alizadeh","year":"2015","journal-title":"Nat Methods"},{"key":"22","doi-asserted-by":"publisher","first-page":"e26476","DOI":"10.7554\/eLife.26476","article-title":"Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data.","volume":"6","author":"Gfeller","year":"2017","journal-title":"Elife"},{"key":"23","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","article-title":"xCell: digitally portraying the tissue cellular heterogeneity landscape.","volume":"1","author":"Butte","year":"2017","journal-title":"Genome Biol"},{"key":"24","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s13059-016-1070-5","article-title":"Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression.","volume":"1","author":"de Reyni\u00e8s","year":"2016","journal-title":"Genome Biol"},{"key":"25","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13073-019-0638-6","article-title":"Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data.","volume":"1","author":"Brouwer","year":"2019","journal-title":"Genome Med"},{"key":"26","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13059-016-1028-7","article-title":"Comprehensive analyses of tumor immunity: implications for cancer immunotherapy.","volume":"1","author":"Liu","year":"2016","journal-title":"Genome Biol"},{"key":"27","doi-asserted-by":"publisher","first-page":"bbab260","DOI":"10.1093\/bib\/bbab260","article-title":"oncoPredict: an R package for predictingor cancer patient drug response and biomarkers from cell line screening data.","volume":"2","author":"Huang","year":"2021","journal-title":"Brief Bioinform"},{"key":"28","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/s41416-021-01488-6","article-title":"Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience.","volume":"12","author":"Milowsky","year":"2021","journal-title":"Br J Cancer"},{"key":"29","doi-asserted-by":"publisher","first-page":"eaar3593","DOI":"10.1126\/science.aar3593","article-title":"Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy.","volume":"36","author":"Joe","year":"2018","journal-title":"Science"},{"key":"30","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","article-title":"TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.","volume":"55","author":"Yang","year":"2018","journal-title":"Nature"},{"key":"31","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.trecan.2023.01.007","article-title":"From gatekeepers to providers: regulation of immune functions by cancer-associated fibroblasts.","volume":"9","author":"Scherz-Shouval","year":"2023","journal-title":"Trends Cancer"},{"key":"32","doi-asserted-by":"publisher","first-page":"6132","DOI":"10.1038\/s41598-021-85137-1","article-title":"Differential gene expression profile between progressive and de novo muscle invasive bladder cancer and its prognostic implication.","volume":"1","author":"Alcaraz","year":"2021","journal-title":"Sci Rep"},{"key":"33","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1016\/j.celrep.2019.04.048","article-title":"Dysregulation of EMT Drives the Progression to Clinically Aggressive Sarcomatoid Bladder Cancer.","volume":"2","author":"Wei","year":"2019","journal-title":"Cell Rep"},{"key":"34","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","article-title":"Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response.","volume":"2","author":"Brown","year":"2018","journal-title":"Nat Med"},{"key":"35","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12943-021-01463-y","article-title":"Cancer associated-fibroblast-derived exosomes in cancer progression.","volume":"2","author":"Ten Dijke","year":"2021","journal-title":"Mol Cancer"},{"key":"36","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.3390\/cancers13051172","article-title":"Cancer-Associated Fibroblast-Induced Resistance to Chemotherapy and Radiotherapy in Gastrointestinal Cancers.","volume":"1","author":"Hur","year":"2021","journal-title":"Cancers (Basel)"},{"key":"37","doi-asserted-by":"publisher","first-page":"e57243","DOI":"10.7554\/eLife.57243","article-title":"Cancer-associated fibroblasts and their influence on tumor immunity and immunotherapy.","volume":"9","author":"Pur\u00e9","year":"2020","journal-title":"Elife"},{"key":"38","doi-asserted-by":"publisher","first-page":"5110","DOI":"10.1038\/s41467-023-40850-5","article-title":"Desmoplastic stroma restricts T cell extravasation and mediates immune exclusion and immunosuppression in solid tumors.","volume":"1","author":"Liousia","year":"2023","journal-title":"Nat Commun"},{"key":"39","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13045-019-0770-1","article-title":"Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy.","volume":"1","author":"Yin","year":"2019","journal-title":"J Hematol Oncol"},{"key":"40","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1073\/pnas.1912109117","article-title":"The circadian clock protein REVERB\u03b1 inhibits pulmonary fibrosis development.","volume":"11","author":"Durrington","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"41","doi-asserted-by":"publisher","first-page":"4180","DOI":"10.1093\/eurheartj\/ehab505","article-title":"Long-term night shift work is associated with the risk of atrial fibrillation and coronary heart disease.","volume":"4","author":"Lu","year":"2021","journal-title":"Eur Heart J"},{"key":"42","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.yjmcc.2017.01.008","article-title":"Disrupting the key circadian regulator CLOCK leads to age-dependent cardiovascular disease.","volume":"10","author":"Martino","year":"2017","journal-title":"J Mol Cell Cardiol"},{"key":"43","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1002\/hep.27049","article-title":"Novel role of nuclear receptor Rev-erb\u03b1 in hepatic stellate cell activation: potential therapeutic target for liver injury.","volume":"5","author":"Schrum","year":"2014","journal-title":"Hepatology"},{"key":"44","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.3390\/cells12121582","article-title":"Circadian Disruption Primes Myofibroblasts for Accelerated Activation as a Mechanism Underpinning Fibrotic Progression in Non-Alcoholic Fatty Liver Disease.","volume":"1","author":"Hanley","year":"2023","journal-title":"Cells"},{"key":"45","doi-asserted-by":"publisher","first-page":"3152","DOI":"10.1016\/j.ajpath.2015.08.003","article-title":"Circadian CLOCK Mediates Activation of Transforming Growth Factor-\u03b2 Signaling and Renal Fibrosis through Cyclooxygenase 2.","volume":"18","author":"Wang","year":"2015","journal-title":"Am J Pathol"},{"key":"46","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1038\/nm.2979","article-title":"Obesity in mice with adipocyte-specific deletion of clock component Arntl.","volume":"1","author":"Fitzgerald","year":"2012","journal-title":"Nat Med"},{"key":"47","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s13577-022-00673-w","article-title":"Development of a CAFs-related gene signature to predict survival and drug response in bladder cancer.","volume":"3","author":"Niu","year":"2022","journal-title":"Hum Cell"},{"key":"48","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s12094-023-03270-x","article-title":"A gene signature of cancer-associated fibroblasts predicts prognosis and treatment response in bladder cancer.","volume":"2","author":"Mo","year":"2024","journal-title":"Clin Transl Oncol"},{"key":"49","doi-asserted-by":"publisher","first-page":"15970","DOI":"10.3390\/ijms232415970","article-title":"Integrated Analysis Revealed an Inflammatory Cancer-Associated Fibroblast-Based Subtypes with Promising Implications in Predicting the Prognosis and Immunotherapeutic Response of Bladder Cancer Patients.","volume":"2","author":"Ji","year":"2022","journal-title":"Int J Mol Sci"},{"key":"50","doi-asserted-by":"publisher","first-page":"107722","DOI":"10.1016\/j.isci.2023.107722","article-title":"A cancer-associated fibroblast subtypes-based signature enables the evaluation of immunotherapy response and prognosis in bladder cancer.","volume":"2","author":"Liu","year":"2023","journal-title":"iScience"},{"key":"51","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/s41416-023-02543-0","article-title":"Systemic anticancer therapy for urothelial carcinoma: UK oncologists\u2019 perspective.","volume":"13","author":"Hussain","year":"2024","journal-title":"Br J Cancer"},{"key":"52","doi-asserted-by":"publisher","first-page":"104236","DOI":"10.1016\/j.critrevonc.2023.104236","article-title":"Predictors of response to neoadjuvant therapy in urothelial cancer.","volume":"19","author":"Swami","year":"2024","journal-title":"Crit Rev Oncol Hematol"},{"key":"53","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1086\/522240","article-title":"Mutations in FAM20C are associated with lethal osteosclerotic bone dysplasia (Raine syndrome), highlighting a crucial molecule in bone development.","volume":"8","author":"Patton","year":"2007","journal-title":"Am J Hum Genet"},{"key":"54","doi-asserted-by":"publisher","first-page":"8039","DOI":"10.3390\/ijms22158039","article-title":"FAM20C Overview: Classic and Novel Targets, Pathogenic Variants and Raine Syndrome Phenotypes.","volume":"2","author":"Palacios-Reyes","year":"2021","journal-title":"Int J Mol Sci"},{"key":"55","doi-asserted-by":"publisher","first-page":"5520","DOI":"10.1073\/pnas.1402218111","article-title":"Dynamic regulation of FGF23 by Fam20C phosphorylation, GalNAc-T3 glycosylation, and furin proteolysis.","volume":"11","author":"Dixon","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"56","doi-asserted-by":"publisher","first-page":"790172","DOI":"10.3389\/fmolb.2021.790172","article-title":"Fam20C in Human Diseases: Emerging Biological Functions and Therapeutic Implications.","volume":"8","author":"Zhang","year":"2021","journal-title":"Front Mol Biosci"},{"key":"57","doi-asserted-by":"publisher","first-page":"113088","DOI":"10.1016\/j.ejmech.2020.113088","article-title":"Discovery of a novel small-molecule inhibitor of Fam20C that induces apoptosis and inhibits migration in triple negative breast cancer.","volume":"21","author":"Zhang","year":"2021","journal-title":"Eur J Med Chem"},{"key":"58","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1038\/s41467-023-36707-6","article-title":"Spatial transcriptomics reveals niche-specific enrichment and vulnerabilities of radial glial stem-like cells in malignant gliomas.","volume":"1","author":"Xu","year":"2023","journal-title":"Nat Commun"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.206088","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T16:13:05Z","timestamp":1726848785000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.206088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,30]]},"references-count":58,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2024,9,15]]}},"alternative-id":["206088","39216004"],"URL":"https:\/\/doi.org\/10.18632\/aging.206088","relation":{},"ISSN":["1945-4589"],"issn-type":[{"type":"electronic","value":"1945-4589"}],"subject":[],"published":{"date-parts":[[2024,8,30]]}}}